Big Moving Stocks for Dec-21 At The Close

These stocks are posting some big moves for today.

ITUS Corp (ITUS) < (ITUS) is currently trading at $3.57 + 0.91 (34.21%) on 151,076 shares traded. ITUS Corp (ITUS) < is +29.82% year-to-date, and +28.78% over the last 12 months.

ITUS Corp funds, develops, acquires and licenses emerging technologies. The Company’s areas of interest include High-Tech, Biotechnology, Life Sciences, and Informatics. Its licensing programs involve encrypted communications, and advanced materials.

NetSol Technologies Inc. (NTWK) < (NTWK) is currently trading at $8.36 + 1.96 (30.69%) on 3,280,854 shares traded. NetSol Technologies Inc. (NTWK) < is +100.58% year-to-date, and +109.75% over the last 12 months.

Netsol Technologies Inc and subsidiaries designs, develops, markets, and exports proprietary software products to customers in the automobile finance and leasing, banking, healthcare, and financial services industries globally.

Cerecor Inc (CERC) < (CERC) is currently trading at $4.06 + 0.94 (30.13%) on 30,132 shares traded. Cerecor Inc (CERC) < is -- year-to-date, and -- over the last 12 months.

Cerecor Inc is a clinical-stage biopharmaceutical company engaged in the development of drugs that make a difference in the lives of patients with neurological and psychiatric disorders.

Amtech Systems Inc. (ASYS) < (ASYS) is currently trading at $7.73 + 1.48 (23.68%) on 152,679 shares traded. Amtech Systems Inc. (ASYS) < is -24.22% year-to-date, and +1.71% over the last 12 months.

Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing, silicon wafer handling automation, and related consumables used in fabricating solar cells, LED and semiconductor devices.

Ocera Therapeutics (OCRX) < (OCRX) is currently trading at $3.62 + 0.62 (20.67%) on 938,977 shares traded. Ocera Therapeutics (OCRX) < is -43.17% year-to-date, and -39.73% over the last 12 months.

Ocera Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease.

Enphase Energy Inc. (ENPH) < (ENPH) is currently trading at $3.57 + 0.56 (18.60%) on 2,351,192 shares traded. Enphase Energy Inc. (ENPH) < is -75.02% year-to-date, and -74.43% over the last 12 months.

Enphase Energy Inc delivers microinverter technology for solar industry that increases energy production, simplifies design and installation, improves system, reduces fire safety risk & provides a platform for intelligent energy management.

Solazyme Inc. (SZYM) < (SZYM) is currently trading at $2.85 + 0.40 (16.33%) on 564,885 shares traded. Solazyme Inc. (SZYM) < is +10.47% year-to-date, and +11.46% over the last 12 months.

Solazyme Inc, along with its subsidiaries, is engaged in providing renewable oils and other bioproducts. It commercializes its products into target markets such as chemicals and fuels, nutrition, and skin and personal care.

Shiloh Industries Inc. (SHLO) < (SHLO) is currently trading at $5.53 + 0.71 (14.73%) on 96,237 shares traded. Shiloh Industries Inc. (SHLO) < is -64.84% year-to-date, and -61.99% over the last 12 months.

Shiloh Industries Inc provides light weighting and noise, vibration and harshness solutions to automotive, commercial vehicle and industrial markets.

Heat Biologics Inc (HTBX) < (HTBX) is currently trading at $2.43 + 0.31 (14.62%) on 30,005 shares traded. Heat Biologics Inc (HTBX) < is -47.06% year-to-date, and -38.79% over the last 12 months.

Heat Biologics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of novel allogeneic, ‘off-the-shelf’ cellular therapeutic vaccines to combat various cancers and infectious diseases.

Aegerion Pharmaceuticals Inc. (AEGR) < (AEGR) is currently trading at $10.30 + 1.29 (14.32%) on 1,736,635 shares traded. Aegerion Pharmaceuticals Inc. (AEGR) < is -50.81% year-to-date, and -54.32% over the last 12 months.

Aegerion Pharmaceuticals Inc is a biopharmaceutical company. The Company currently operates in one business segment focusing on the development and commercialization of its product, lomitapide.

Alex Fredricks

Alex Fredricks

Alex Fredricks has a degree in business and is an avid day-trader. Alex's experience and love for the game of the markets is shown not only in his posts, but the post he helps edit for other authors on our staff.